NASDAQ: OLMA

Olema Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

The consensus among 4 Wall Street analysts covering (NASDAQ: OLMA) stock is to Strong Buy OLMA stock.

Out of 4 analysts, 2 (50%) are recommending OLMA as a Strong Buy, 2 (50%) are recommending OLMA as a Buy, 0 (0%) are recommending OLMA as a Hold, 0 (0%) are recommending OLMA as a Sell, and 0 (0%) are recommending OLMA as a Strong Sell.

If you're new to stock investing, here's how to buy Olema Pharmaceuticals stock.

(NASDAQ: OLMA) Olema Pharmaceuticals's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.64%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.1%.

Olema Pharmaceuticals's revenue in 2024 is $0.On average, 2 Wall Street analysts forecast OLMA's revenue for 2026 to be $815,796,071, with the lowest OLMA revenue forecast at $373,510,470, and the highest OLMA revenue forecast at $1,258,081,673. On average, 2 Wall Street analysts forecast OLMA's revenue for 2027 to be $1,452,105,824, with the lowest OLMA revenue forecast at $1,235,715,776, and the highest OLMA revenue forecast at $1,668,495,871.

In 2028, OLMA is forecast to generate $17,072,727,443 in revenue, with the lowest revenue forecast at $3,919,623,344 and the highest revenue forecast at $30,225,831,542.

According to 4 Wall Street analysts that have issued a 1 year OLMA price target, the average OLMA price target is $22.50, with the highest OLMA stock price forecast at $25.00 and the lowest OLMA stock price forecast at $20.00.

On average, Wall Street analysts predict that Olema Pharmaceuticals's share price could reach $22.50 by Apr 2, 2025. The average Olema Pharmaceuticals stock price prediction forecasts a potential upside of 127.96% from the current OLMA share price of $9.87.

(NASDAQ: OLMA) forecast ROE is N/A, which is considered weak.